BioMarin Pharmaceutical | BMRN - SCHULD

Aktienkurs
54.06
Täglich Wechseln
0.15 0.28%
Monatlich
-2.59%
Jährlich
-12.85%
Q2 Prognose
52.04




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amgen USD 54.6B 17M 2025-12
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Gilead Sciences USD 24.94B 5M 2025-12
Incyte USD 40.41M 855K 2025-12
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Moderna USD 1.31B 571M 2025-12
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09